drugset / Trial / NCT00232154

A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

NCT00232154

Phase 2 Completed 72 enrolled Pfizer
RandomizedParallel-groupOpen-label

Summary

To measure the level of drug in nasal tissue and blood after taking a single 2g dose or 500mg tablets for up to 3 days.

Timeline

Start
2005-11
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 500 mg Oral
Subject Azithromycin Small molecule 2 g Oral

Indications